Spotify (SPOT) Rose 148% in 2024
https://finance.yahoo.com/news/spotify-spot-rose-148-2024-120038786.html
Jerome Lambert took an unlikely career step down from Richemont’s CEO to leading one of its 29 brands—he said he just wanted to return to ‘the job I loved’
Jerome Lambert went from being Richemont Group’s CEO, to its COO and then, CEO of its Jaeger-LeCoultre Maison—all in a span of six months.
AI and Trump 2.0 propel Softbank CEO Masayoshi Son back into the spotlight
Leading OpenAI’s record-breaking $40 billion funding round shows the tech investor’s knack for seizing big opportunities.
Don’t count on America’s wealthiest to help people struggling during the recession—philanthropic spending could go down, experts say
Financial experts say a recession could lower donating among the lower rungs of the 1%.
Inside Amazon’s stealthy chip lab powering its $8 billion AI bet on Anthropic
Amazon acquired a stealthy chip startup a decade ago. Now that company is a key player in Amazon’s cloud AI strategy—and its huge investment in Anthropic.
Is This Bargain Stock Poised for a Bull Run?
The S&P 500 might be trading 7% below the record high it touched in February, but investors are still concerned about high stock valuations. This makes perfect sense in the wake of the index’s strong gains in 2023 and 2024. Across those two years, it rose by about 53%.But all hope isn’t lost for those still trying to find some reasonably valued equities to add to their portfolios. For those willing to look at beaten-down companies, there might still be lucrative opportunities to allocate capital with a long-term mindset.As of March 25, one fintech stock was trading 77% off the peak it reached in July 2021, when COVID-19 was still a global health crisis. While the market’s enthusiasm for this company has fallen, the fundamentals of the business could justify more optimism.Continue readinghttps://www.fool.com/investing/2025/04/01/is-this-bargain-stock-ready-for-a-bull-run/
Beat the S&P 500 With This Cash-Gushing Dividend Stock
Investors seeking relief from stock market volatility should take a closer look at Bristol Myers Squibb (NYSE: BMY). At the time of writing, shares of the healthcare giant have climbed 4% year to date — a notable outlier amid the broader stock market sell-off, with the S&P 500 index currently down nearly 10% from its peak.Better-than-expected financial results in recent quarters have signaled an improved outlook, helping to sustain the rally. Even more appealing is Bristol Myers Squibb’s 4% dividend yield, making it an excellent choice for investors seeking regular portfolio income.Here’s why this cash-generating biopharmaceutical leader is poised to continue outperforming the S&P 500.Continue readinghttps://www.fool.com/investing/2025/04/01/beat-the-sp-500-with-this-cash-gushing-dividend/
Nio’s Stock Is About the Cheapest It’s Ever Been. 1 Thing to Know Before You Buy.
Nio is a dirt cheap EV stock to buy now.
American Tower: I’m Dollar-Cost-Averaging For Dividend Power
https://seekingalpha.com/article/4772193-american-tower-dollar-cost-averaging-dividend-power?source=feed_all_articles
UDOW And Leveraged ETFs Drift Update
https://seekingalpha.com/article/4772054-udow-and-leveraged-etfs-drift-update?source=feed_all_articles